Results 191 to 200 of about 93,643 (333)

Complement dysregulation in human tauopathies

open access: yesBrain Pathology, Volume 35, Issue 6, November 2025.
Complement protein and activation product levels were assessed in post‐mortem frontal cortex from three distinct subtypes of Tauopathy: Corticobasal degeneration, globular glial tauopathy, and Pick's disease. Quantification of complement proteins by immunohistochemistry and ELISA showed elevation of key complement proteins (C1q) regulators (FI) and ...
Jacqui Nimmo   +3 more
wiley   +1 more source

International approaches to frontotemporal dementia diagnosis: From social cognition to neuropsychology [PDF]

open access: bronze, 2003
Bruce L. Miller   +5 more
openalex   +1 more source

Novel differentially expressed genes and multiple biological pathways for Alzheimer's disease identified in brain tissue from African American donors

open access: yesAlzheimer's &Dementia, Volume 21, Issue 10, October 2025.
Abstract INTRODUCTION Few African American (AA) donors have been included in post mortem Alzheimer's disease (AD) studies compared to European‐ancestry (EA) individuals. METHODS We generated transcriptome‐wide bulk pre‐frontal cortex (PFC) gene expression data from 125 AA donors with neuropathologically determined AD and 82 AA controls.
Mark W. Logue   +25 more
wiley   +1 more source

Tau Protein in Frontotemporal Dementia Linked to Chromosome 3 (FTD-3) [PDF]

open access: bronze, 2003
Despina Yancopoulou   +5 more
openalex   +1 more source

Acoustically Altered Speech Perception in Frontotemporal Dementia Syndromes. [PDF]

open access: yesNeurology
Johnson JCS   +8 more
europepmc   +1 more source

Sex differences in vulnerability to tau pathology: Impact on cognitive decline

open access: yesAlzheimer's &Dementia, Volume 21, Issue 10, October 2025.
Abstract INTRODUCTION Although the link between the presence of amyloid and tau pathologies, neurodegeneration, and cognitive decline in aging individuals is established, it is less clear whether there are sex differences in vulnerability to these pathologies.
Yashar Zeighami   +2 more
wiley   +1 more source

Familial Frontotemporal Dementia: From Gene Discovery to Clinical Molecular Diagnostics [PDF]

open access: bronze, 2003
Vivianna M. Van Deerlin   +4 more
openalex   +1 more source

Striatal dopaminergic patterns and clinical features in frontotemporal dementia. [PDF]

open access: yesBrain Commun
Urso D   +10 more
europepmc   +1 more source

White matter hyperintensities precede other biomarkers in GRN frontotemporal dementia

open access: yesAlzheimer's &Dementia, Volume 21, Issue 10, October 2025.
Abstract INTRODUCTION Increased white matter hyperintensities (WMHs) have been reported in genetic frontotemporal dementia (FTD) in small studies, but the sequence of WMH abnormalities relative to other biomarkers is unclear. METHODS Using a large dataset (n = 763 GENFI2 participants), we measured WMHs and examined them across genetic FTD variants and ...
Mahdie Soltaninejad   +38 more
wiley   +1 more source

Home - About - Disclaimer - Privacy